Dual-specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) in human disease, an overview

MF Lindberg, L Meijer - International Journal of Molecular Sciences, 2021 - mdpi.com
Dual-specificity tyrosine phosphorylation-regulated kinases (DYRK1A, 1B, 2-4) and cdc2-
like kinases (CLK1-4) belong to the CMGC group of serine/threonine kinases. These protein …

An overview of kinase downregulators and recent advances in discovery approaches

B Wang, H Wu, C Hu, H Wang, J Liu… - Signal Transduction and …, 2021 - nature.com
Since the clinical approval of imatinib, the discovery of protein kinase downregulators
entered a prosperous age. However, challenges still exist in the discovery of kinase …

[HTML][HTML] Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee …

V Deshmukh, AL O'Green, C Bossard, T Seo… - Osteoarthritis and …, 2019 - Elsevier
Objectives Wnt pathway upregulation contributes to knee osteoarthritis (OA) through
osteoblast differentiation, increased catabolic enzymes, and inflammation. The small …

[HTML][HTML] The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models

BY Tam, K Chiu, H Chung, C Bossard, JD Nguyen… - Cancer letters, 2020 - Elsevier
The Wnt/β-catenin signaling pathway is aberrantly activated in colorectal (CRC) and many
other cancers, and novel strategies for effectively targeting it may be needed due to its …

Role of protein phosphorylation in cell signaling, disease, and the intervention therapy

K Pang, W Wang, JX Qin, ZD Shi, L Hao, YY Ma… - MedComm, 2022 - Wiley Online Library
Protein phosphorylation is an important post‐transcriptional modification involving an
extremely wide range of intracellular signaling transduction pathways, making it an …

Therapeutic targeting of alternative splicing: a new frontier in cancer treatment

AJ Murphy, AH Li, P Li, H Sun - Frontiers in oncology, 2022 - frontiersin.org
The ability for cells to harness alternative splicing enables them to diversify their proteome in
order to carry out complex biological functions and adapt to external and internal stimuli. The …

Dual-target kinase drug design: Current strategies and future directions in cancer therapy

D Sun, Y Zhao, S Zhang, L Zhang, B Liu… - European Journal of …, 2020 - Elsevier
Protein kinases are well-known to orchestrate the activation of signaling cascades in
response to extracellular and intracellular stimuli to control cell proliferation and survival …

Development of MPS1 inhibitors: recent advances and perspectives

Y Zeng, X Ren, P Jin, Y Zhang, M Zhuo… - Journal of Medicinal …, 2023 - ACS Publications
Monopolar spindle kinase 1 (MPS1) plays a pivotal role as a dual-specificity kinase
governing spindle assembly checkpoint activation and sister chromatid separation in …

Biology of the mRNA splicing machinery and its dysregulation in cancer providing therapeutic opportunities

M Blijlevens, J Li, VW van Beusechem - International journal of molecular …, 2021 - mdpi.com
Dysregulation of messenger RNA (mRNA) processing—in particular mRNA splicing—is a
hallmark of cancer. Compared to normal cells, cancer cells frequently present aberrant …

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy

Y Zhang, Y Zhang, L Zhang - Journal of cancer research and clinical …, 2019 - Springer
Purpose Esophageal cancer is a common disease in China with low survival rate due to no
obvious early symptoms and lack of effective screening strategies. Traditional treatments …